The overall goal of the diAB-RDCC is to stimulate collaborative and innovative interdisciplinary research in order to enhance our fundamental understanding of disease mechanisms and their application to human rheumatic diseases. Through this understanding, the UAB-RDCC's goal is to improve the diagnosis and treatment of patients with arthritis and musculoskeletal diseases. The strategy of the UAB-RDCC is to draw on the strengths of the UAB research community, including the Hudson Alpha Institute of Biotechnology and Southern Research, to provide essential scientific tools and technologies, to enlist new investigators, to foster the sharing of knowledge and to nuture collaborations among translational and basic science investigators in the fight against rheumatic diseases through the creation and support of a vibrant scientific culture of discovery and innovation. Accordingly, our specific aims are 1) to facilitate rheumatic disease research through Research Core facilities, which provide scientifically rigorous, state-of-the-art techniques necessary for improved understanding of disease pathogenesis and the development of new treatments;2) to support outstanding Pilot &Feasibility research projects drawing on the unique strengths of the RDCC research base and using innovative tools and approaches in biomedical science;and 3) to provide career development and career enrichment activities to enhance both the mentorship of talented investigators as independent researchers and the continuing education of all of our investigators. To achieve its specific aims, the UAB-RDCC has worked continuously with its Research Core facilities to develop technical capacities, to assess user needs and to provide a variety of formats for outreach and enrichment, including our IDEAs program (individualized design and experimental analyses sessions). The RDCC leadership team has worked with the School of Medicine, the Provost, the Vice President for Research and the Faculty Practice (HSF-GEF) to support the continued development of available tools and technologies for rheumatic diseases research, and through these efforts the UAB-RDCC provides the opportunity for our investigators to commit their programs to the mission of NIAMS.

Public Health Relevance

The UAB-RDCC is committed to providing both the critical tools and technologies and the vibrant scientific environment to enhance discovery and innovation in rheumatic diseases research in order to improve the diagnosis and treatment of patients with arthritis and musculoskeletal diseases. To achieve these goals, the UAB-RDCC provides core facilities and supports both pilot research programs and a vigorous outreach and enrichment program of seminars, symposia, workshops and individualized IDEA sessions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR048311-12
Application #
8536205
Study Section
Special Emphasis Panel (ZAR1-KM (M1))
Program Officer
Mao, Su-Yau
Project Start
2001-09-28
Project End
2017-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
12
Fiscal Year
2013
Total Cost
$560,493
Indirect Cost
$176,840
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Pasek, Raymond C; Malarkey, Erik; Berbari, Nicolas F et al. (2016) Coiled-coil domain containing 42 (Ccdc42) is necessary for proper sperm development and male fertility in the mouse. Dev Biol 412:208-18
Holt, Leanne Melissa; Olsen, Michelle Lynne (2016) Novel Applications of Magnetic Cell Sorting to Analyze Cell-Type Specific Gene and Protein Expression in the Central Nervous System. PLoS One 11:e0150290
Zhao, Jian; Giles, Brendan M; Taylor, Rhonda L et al. (2016) Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis 75:242-52
Pegues, Melissa A; McWilliams, Ian L; Szalai, Alexander J (2016) C-reactive protein exacerbates renal ischemia-reperfusion injury: are myeloid-derived suppressor cells to blame? Am J Physiol Renal Physiol 311:F176-81
Sun, Jim; Schaaf, Kaitlyn; Duverger, Alexandra et al. (2016) Protein phosphatase, Mg2+/Mn2+-dependent 1A controls the innate antiviral and antibacterial response of macrophages during HIV-1 and Mycobacterium tuberculosis infection. Oncotarget 7:15394-409
Yang, Zhenhua; Shah, Kushani; Khodadadi-Jamayran, Alireza et al. (2016) Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells. J Exp Med 213:2349-2364
Padgett, Lindsey E; Tse, Hubert M (2016) NADPH Oxidase-Derived Superoxide Provides a Third Signal for CD4 T Cell Effector Responses. J Immunol 197:1733-42
Hull, Travis D; Boddu, Ravindra; Guo, Lingling et al. (2016) Heme oxygenase-1 regulates mitochondrial quality control in the heart. JCI Insight 1:e85817
Jackson, Joshua D; Markert, James M; Li, Li et al. (2016) STAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells. Mol Cancer Res 14:482-92
Schultz, Matthew J; Holdbrooks, Andrew T; Chakraborty, Asmi et al. (2016) The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype. Cancer Res 76:3978-88

Showing the most recent 10 out of 267 publications